Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease with no disease modifying treatments or therapies available…
See where grants have been awarded across Minnesota.
Zhe Chen, PhD
Vision impairment that results from optic nerve damage, such as from glaucoma, poses a significant challenge to public health. To date, there are no…
2024-2026
Patrick Walsh, MS
Anatomic, a University of Minnesota start-up company based in Minnesota, develops neural tissues used in basic science and drug development. Its…
2024-2026
Michael Barry, PhD
Propionic acidemia (PA) is a severe metabolic disorder caused by mutations in the PCCA gene. Traditional treatments, including stringent life-long…
2024-2028
Our goal with this grant is to push innovation to increase yield and lower production cost for targeted proteins, using molecular farming.…
2022-2023
LEAH Labs is an innovative biotech startup headquartered at Mayo Clinic's 'Hatchery Lab' developing regenerative cell therapies, first focused on…
2022-2023
This project aims to develop and implant a preclinical model of a regenerative tissue tube for nerve repair. The TRUE™ Tissue allogeneic biomaterial…
2022-2023
1) Build and test a customer demonstration model of the liquid nitrogen-free cryogenic storage system. This system will allow storage and…
2022-2023
We are developing a one-time treatment for durable remission of HIV, after which patients will no longer need to take traditional antiretroviral…
2022-2023
Our ultimate goal is to bring our chondrocyte product, harvested from human induced pluripotent cell derived multi tissue organoids, into human…
2022-2024
To elucidate how muscle vascular regeneration is regulated during muscle remodeling.
To identify the interactions between muscle stem cells and…
2022-2024
The goal of this project is to describe a new field of science: peroxisome transfer. This has never been shown, and we are poised to be the first lab…
2022-2024